The global Haematococcus Pluvialis market is expected to grow at a significant CAGR during the forecast period. Haematococcus Pluvialis, microalgae, is a promising source of astaxanthin. During the red development phase, it accumulates as a colourful and antioxidant carotenoid. Due to its enhanced antioxidant activity and capacity to cure illnesses, algae-based astaxanthin is widely used in medicinal applications. The capacity of the vibrant red carotenoid to quench free radicals and reduce oxidative stress has been verified by new research that has connected cardiovascular health advantages, sports nutrition, and recovery, and skin and joint health.
Human food and dietary supplements almost entirely include natural algae astaxanthin. Major Neurodegenerative illnesses such as Parkinson's, Alzheimer's, Huntington's, and amyotrophic lateral sclerosis-ALS all include oxidative stress as a causative or auxiliary component in their aetiology. In animals natural astaxanthin may penetrate the blood-brain barrier, extending its antioxidant effects beyond the barrier.
As a result, astaxanthin may help in the treatment of Alzheimer's disease and other neurological diseases. Due to that, there is a growing demand for natural astaxanthin antioxidant supplements derived from Haematococcus in the nutraceutical industry due to its potential effects on a variety of diseases including neurodegenerative, gastrointestinal, liver, skin diseases, cardiovascular, cancers, diabetes, and hypertension which is further driving the market.
Market Coverage
o By Type
o By Application
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Haematococcus Pluvialis Market by Segments
By Type
o Astaxanthin Ingredients
o Astaxanthin Bulk Finished Products
By Application
o Food and Beverage
o Nutraceuticals
o Pharmaceuticals
o Cosmetics
Global Haematococcus Pluvialis Market by Region
North America
Europe
Asia-Pacific
Rest of the World